For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $340.62 in the prior trading day, HCA Healthcare Inc (NYSE: HCA) closed at $335.55, down -1.49%. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 1.01 million shares were traded. HCA stock price reached its highest trading level at $341.39 during the session, while it also had its lowest trading level at $335.255.
Ratios:
Our goal is to gain a better understanding of HCA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.65. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.08.
Wells Fargo Downgraded its Equal Weight to Underweight on November 25, 2024, whereas the target price for the stock was revised from $400 to $320.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 14 ’25 when Berres Jennifer sold 9,533 shares for $322.59 per share. The transaction valued at 3,075,240 led to the insider holds 15,412 shares of the business.
Berres Jennifer bought 9,533 shares of HCA for $3,075,238 on Feb 14 ’25. On Feb 11 ’25, another insider, Reiner Deborah M, who serves as the Former Officer of the company, bought 3,510 shares for $322.39 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCA now has a Market Capitalization of 82613420032 and an Enterprise Value of 129601126400. As of this moment, HCA’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.26, and their Forward P/E ratio for the next fiscal year is 12.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17. Its current Enterprise Value per Revenue stands at 1.836 whereas that against EBITDA is 9.351.
Stock Price History:
The Beta on a monthly basis for HCA is 1.46, which has changed by 0.07883489 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, HCA has reached a high of $417.14, while it has fallen to a 52-week low of $289.98. The 50-Day Moving Average of the stock is 2.31%, while the 200-Day Moving Average is calculated to be -2.93%.
Shares Statistics:
The stock has traded on average 1.72M shares per day over the past 3-months and 1867750 shares per day over the last 10 days, according to various share statistics. A total of 249.98M shares are outstanding, with a floating share count of 174.51M. Insiders hold about 29.12% of the company’s shares, while institutions hold 65.64% stake in the company. Shares short for HCA as of 1743379200 were 5576020 with a Short Ratio of 3.24, compared to 1740700800 on 5891356. Therefore, it implies a Short% of Shares Outstanding of 5576020 and a Short% of Float of 3.18.
Dividends & Splits
In the trailing 12 months, HCA’s forward annual dividend rate was 2.64, compared to 2.70 this year. Against a Trailing Annual Dividend Yield of 0.007750573The stock’s 5-year Average Dividend Yield is 0.8.
